CE-LIF method for the separation of Anthracyclines: Application to protein binding analysis in plasma using ultrafiltration

Journal of Separation Science

Volumn 31, Issue 10, 2008, Pages 1828-1833

  Whitaker, Gillian ^a   Liliquist, Amy ^a   Pasas, Stephanie A ^a   O'Connor, Robert ^b   Regan, Fiona ^b   Lunte, Craig E ^a   Smyth, Malcolm R ^b  

^a UNIVERSITY OF KANSAS   (United States)

^b DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Anthracyclines; Capillary electrophoresis; Laser induced fluorescence; Plasma; Ul trafiltration

Indexed keywords

CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; ISOMERS; LASER PRODUCED PLASMAS; PLASMAS; SEPARATION; ULTRAFILTRATION;

ANTHRACYCLINES; BORATE BUFFERS; CHEMOTHERAPEUTIC DRUGS; CROSS-ENTROPY (CE) METHOD; DAUNORUBICIN (DNR); DOXORUBICIN (DOX); EMISSION WAVE LENGTH; EPIRUBICIN; IN-VITRO; OVARIAN CANCERS; PROTEIN BINDINGS; SIMULTANEOUS DETERMINATIONS;

BIOCHEMISTRY;

ANTHRACYCLINE; BORIC ACID; BUFFER; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN;

ARTICLE; CANCER CHEMOTHERAPY; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DRUG PROTEIN BINDING; FLUORESCENCE; IN VITRO STUDY; LASER INDUCED FLUORESCENCE; LUNG CANCER; OVARY CANCER; PRIORITY JOURNAL; REPRODUCIBILITY; ULTRAFILTRATION;

ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BORATES; DAUNORUBICIN; DOXORUBICIN; ELECTROPHORESIS, CAPILLARY; EPIRUBICIN; HUMANS; METHANOL; MODELS, CHEMICAL; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; ULTRAFILTRATION;

EID: 46249114010     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.200700629     Document Type: Article

References (40)

1. Weiss, R. B., Semin. Oncol. 1992, 19, 670-686.
2. Loadman, P.M., Calabrese, C. R. J. Chromatogr. B 2001, 764, 193-206.
3. Zagotto, G., Gatto, B., Moro, S., Sissi, C., Palumbo, M., J. Chromatogr. B 2001, 764, 161-171.
4. Hempel, G., Flege, S., Wurthwein, G., Boos, J., Cancer Chemother. Pharmacol. 2002, 49, 133-141.
5. Minckwitz, G. V., Expert Opin. Pharmacother. 2007, 8, 485-495.
6. Booser, D.J., Hortobagyi, G. N., Drugs 1994, 47, 223-258.
7. Ceruti, M., Tagini, V., Recalenda, V., Arpicco, S., Cattel, L., Airoldi, M., Bumma, C., Farmaco 1999, 54, 733-739.
8. Berruti, A., Bitossi, R., Bottini, A., Bonardi, S., Donadio, M., Nigro, C., Bertetto, O., Danese, S., Bertone, E., Sarobba, M. G., Farris, A., Katsaros, D., Castiglone, F., Volpe, T., Lattuada, S., Mancarella, S., Dogliotti, L., J. Pharm. Biomed. Anal. 2005, 41, 249-255.
9. Sarre, S., Belle, K. V., Smolders, I., Krieken, G., Michotte, Y., J. Pharm. Biomed. Anal. 1992, 10, 735-739.
10. Celio, L. A., DiGregorio, G. J., Ruch, E., Pace, J. N., Piraino, A. J., Arch. Int. Pharmacodyn. 1982, 260, 180-188.
11. Sebille, B., Fundam. Clin. Pharmacol. 1990, 4, 151s-161s.
12. Pacifici, G. M., Viani, A., Clin. Pharmaco. Concepts 1992, 23, 449-468.
13. Celio, L. A., DiGregorio, G. J., Ruch, E., Pace, J., Piraino, A. J., Eur. J. Clin. Pharmacol. 1983, 24, 261-266.
14. Eksborg, S., Ehrsson, H., Ekqvist, B., Cancer Chemother. Pharmacol. 1982, 10, 7-10.
15. Chassany, O., Urien, S., Claudepierre, P., Bastian, G., Tillement, J. P., Cancer Chemother. Pharmacol. 1996, 38, 571-573.
16. Sandstrom, M., Simonsen, L. E., Freijs, A., Karlsson, M. O., Cancer Chemother. Pharmacol. 1999, 44, 469-474.
17. Emara, S., Morita, I., Tamura, K., Razee, S., Masujima, T., Mohamed, H. A., El-Gizaway, S. M., El-Rabbat, N. A., Talanta 1994, 41, 1973-1980.
18. Mahnik, S. N., Rizovski, B., Fuerhacker, M., Mader, R. M., Chemosphere 2006, 65, 1419-1425.
19. Ricciarello, R., Pichini, S., Pacifici, R., Altieri, I., Pellegrini, M., Fattorossi, A., Zuccaro, P., J. Chromatogr. B 1998, 707, 219-225.
20. Hulhoven, R., Desager, J. P. J. Chromatogr. 1976, 125, 369-374.
21. Badea, I., Lazar, L., Moja, D., Nicolescu, D., Tudose, A., J. Pharm. Biomed. Anal. 2005, 39, 305-309.
22. Wall, R., McMahon, G., Crown, J., Clynes, M., O'Connor, R., Talanta 2007, 72, 145-154.
23. Reinhoud, N. J., Tjaden, U. R., Irth, H., Greef, J. V. D., J. Chromatogr. B 1992, 574, 327-334.
24. Perez-Ruiz, T., Martinez-Lozano, C., Sanz, A., Bravo, E., Electrophoresis 2001, 22, 134-138.
25. Simeon, N., Chatelut, E., Canal, P., Nertz, M., Couderc, F., J. Chromatogr. A 1999, 853, 449-454.
26. Gavenda, A., Sevick, J., Psotova, J., Bednar, P., Bartak, P., Adamovsky, P., Simanek, V., Electrophoresis 2001, 22, 2782-2785.
27. Hempel, G., Schulze-Westhoff, P., Flege, S., Boos, J., J. Chromatogr. B 2001, 758, 221-228.
28. Hu, Q., Zhang, L., Zhou, T., Fang, Y., Anal. Chim. Acta 2000, 416, 15-19.
29. Griese, N., Blashcke, G., Boos, J., Hempel, G., J. Chromatogr. A 2002, 979, 379-388.
30. Andersen, A., Holte, H., Slordal, L., Cancer Chemother. Pharmacol. 1999, 44, 422-426.
31. Raghunand, N., Gillies, R. J., Drug Resist. Updat. 2000, 8, 39-47.
32. Tomlinson, E., Malspeis, L., J. Pharm. Sci. 1982, 71, 1121-1125.
33. Lucas, C., Foley, J. P., Ahuja, E. S., Biomed. Chromatogr. 2003, 17, 172-181.
34. Landers, J. P., Handbook of Capillary Electrophoresis, CRC Press, Boca Raton 1997.
35. Shihabi, Z. K., J. Chromatogr. A 1993, 652, 471-475.
36. Shihabi, Z. K., J. Capillary Electrophor. 1995, 6, 267-271.
37. Phinney, K. W., Jackson, J. W., Sander, L. C., Electrophoresis 2002, 23, 1308-1313.
38. Quellec, A. L., Dupin, S., Tufenkji, A. E., Genissel, P., Houin, G., Pharm. Res. 1994, 11, 835-838.
39. Lunte, C. E., Scott, D. O., Herrera, A. D. M., Curr. Sep. 1991, 10, 41-44.
40. Herrera, A. M., Scott, D. O., Lunte, C. E., Pharm. Res. 1990, 7, 1077-1081.